Polychlorinated biphenyls, cytochrome P4501A1 polymorphism, and postmenopausal breast cancer risk

Kirsten B. Moysich, Peter G. Shields, Jo L. Freudenheim, Enrique F. Schisterman, John E. Vena, Paul Kostyniak, Hebe Greizerstein, James R. Marshall, Saxon Graham, Christine B. Ambrosone

Research output: Contribution to journalArticle

Abstract

In experimental systems, polychlorinated biphenyls (PCBs) induce cytochrome P4501A1 (CYP1A1), which is involved in metabolism of steroid hormones and polycyclic aromatic hydrocarbons in humans. A genetic polymorphism coding for a valine to isoleucine substitution in exon 7 has been associated with lung cancer risk in Japanese populations. In a previous study, we found no association between CYP1A1 genotype and breast cancer risk. However, we were interested in determining whether genotype would relate to risk when PCB body burden was taken into account. In a subset of a case-control study in western New York, 154 postmenopausal women with incident, primary, histologically confirmed postmenopausal breast cancer and 192 community controls were interviewed and underwent phlebotomy. Serum levels of 56 PCB peaks were determined by high resolution gas chromatography with electron capture. PCR-RFLP analyses of the CYP1A1 polymorphism were performed. Unconditional logistic regression was used to compute adjusted odds ratios and 95% confidence intervals. Among women with serum PCB levels above the median of the distribution in the control group, there was increased risk of breast cancer associated with the presence of at least one valine allele, compared with women who were homozygous for the isoleucine alleles (odds ratio, 2.93; 95% confidence interval, 1.17-7.36). Among women with low PCB body burden, no association between CYP1A1 genotype and breast cancer risk was observed. Adjustment for serum lipids and body mass index did not affect the magnitude of the observed associations. PCB body burden may modify the effect of the polymorphism on postmenopausal breast cancer risk through increased CYP1A1 enzyme induction or by activation by specific PCB congeners. These results should be considered preliminary, pending replication by other studies.

Original languageEnglish (US)
Pages (from-to)41-44
Number of pages4
JournalCancer Epidemiology Biomarkers and Prevention
Volume8
Issue number1
StatePublished - Jan 1999
Externally publishedYes

Fingerprint

Polychlorinated Biphenyls
Cytochromes
Breast Neoplasms
Body Burden
Isoleucine
Genotype
Valine
Serum
Alleles
Odds Ratio
Confidence Intervals
Enzyme Induction
Phlebotomy
Polycyclic Aromatic Hydrocarbons
Genetic Polymorphisms
Restriction Fragment Length Polymorphisms
Gas Chromatography
Case-Control Studies
Exons
Lung Neoplasms

ASJC Scopus subject areas

  • Epidemiology
  • Oncology

Cite this

Moysich, K. B., Shields, P. G., Freudenheim, J. L., Schisterman, E. F., Vena, J. E., Kostyniak, P., ... Ambrosone, C. B. (1999). Polychlorinated biphenyls, cytochrome P4501A1 polymorphism, and postmenopausal breast cancer risk. Cancer Epidemiology Biomarkers and Prevention, 8(1), 41-44.

Polychlorinated biphenyls, cytochrome P4501A1 polymorphism, and postmenopausal breast cancer risk. / Moysich, Kirsten B.; Shields, Peter G.; Freudenheim, Jo L.; Schisterman, Enrique F.; Vena, John E.; Kostyniak, Paul; Greizerstein, Hebe; Marshall, James R.; Graham, Saxon; Ambrosone, Christine B.

In: Cancer Epidemiology Biomarkers and Prevention, Vol. 8, No. 1, 01.1999, p. 41-44.

Research output: Contribution to journalArticle

Moysich, KB, Shields, PG, Freudenheim, JL, Schisterman, EF, Vena, JE, Kostyniak, P, Greizerstein, H, Marshall, JR, Graham, S & Ambrosone, CB 1999, 'Polychlorinated biphenyls, cytochrome P4501A1 polymorphism, and postmenopausal breast cancer risk', Cancer Epidemiology Biomarkers and Prevention, vol. 8, no. 1, pp. 41-44.
Moysich KB, Shields PG, Freudenheim JL, Schisterman EF, Vena JE, Kostyniak P et al. Polychlorinated biphenyls, cytochrome P4501A1 polymorphism, and postmenopausal breast cancer risk. Cancer Epidemiology Biomarkers and Prevention. 1999 Jan;8(1):41-44.
Moysich, Kirsten B. ; Shields, Peter G. ; Freudenheim, Jo L. ; Schisterman, Enrique F. ; Vena, John E. ; Kostyniak, Paul ; Greizerstein, Hebe ; Marshall, James R. ; Graham, Saxon ; Ambrosone, Christine B. / Polychlorinated biphenyls, cytochrome P4501A1 polymorphism, and postmenopausal breast cancer risk. In: Cancer Epidemiology Biomarkers and Prevention. 1999 ; Vol. 8, No. 1. pp. 41-44.
@article{19badf3420f34e55a12af5efbee314f7,
title = "Polychlorinated biphenyls, cytochrome P4501A1 polymorphism, and postmenopausal breast cancer risk",
abstract = "In experimental systems, polychlorinated biphenyls (PCBs) induce cytochrome P4501A1 (CYP1A1), which is involved in metabolism of steroid hormones and polycyclic aromatic hydrocarbons in humans. A genetic polymorphism coding for a valine to isoleucine substitution in exon 7 has been associated with lung cancer risk in Japanese populations. In a previous study, we found no association between CYP1A1 genotype and breast cancer risk. However, we were interested in determining whether genotype would relate to risk when PCB body burden was taken into account. In a subset of a case-control study in western New York, 154 postmenopausal women with incident, primary, histologically confirmed postmenopausal breast cancer and 192 community controls were interviewed and underwent phlebotomy. Serum levels of 56 PCB peaks were determined by high resolution gas chromatography with electron capture. PCR-RFLP analyses of the CYP1A1 polymorphism were performed. Unconditional logistic regression was used to compute adjusted odds ratios and 95{\%} confidence intervals. Among women with serum PCB levels above the median of the distribution in the control group, there was increased risk of breast cancer associated with the presence of at least one valine allele, compared with women who were homozygous for the isoleucine alleles (odds ratio, 2.93; 95{\%} confidence interval, 1.17-7.36). Among women with low PCB body burden, no association between CYP1A1 genotype and breast cancer risk was observed. Adjustment for serum lipids and body mass index did not affect the magnitude of the observed associations. PCB body burden may modify the effect of the polymorphism on postmenopausal breast cancer risk through increased CYP1A1 enzyme induction or by activation by specific PCB congeners. These results should be considered preliminary, pending replication by other studies.",
author = "Moysich, {Kirsten B.} and Shields, {Peter G.} and Freudenheim, {Jo L.} and Schisterman, {Enrique F.} and Vena, {John E.} and Paul Kostyniak and Hebe Greizerstein and Marshall, {James R.} and Saxon Graham and Ambrosone, {Christine B.}",
year = "1999",
month = "1",
language = "English (US)",
volume = "8",
pages = "41--44",
journal = "Cancer Epidemiology Biomarkers and Prevention",
issn = "1055-9965",
publisher = "American Association for Cancer Research Inc.",
number = "1",

}

TY - JOUR

T1 - Polychlorinated biphenyls, cytochrome P4501A1 polymorphism, and postmenopausal breast cancer risk

AU - Moysich, Kirsten B.

AU - Shields, Peter G.

AU - Freudenheim, Jo L.

AU - Schisterman, Enrique F.

AU - Vena, John E.

AU - Kostyniak, Paul

AU - Greizerstein, Hebe

AU - Marshall, James R.

AU - Graham, Saxon

AU - Ambrosone, Christine B.

PY - 1999/1

Y1 - 1999/1

N2 - In experimental systems, polychlorinated biphenyls (PCBs) induce cytochrome P4501A1 (CYP1A1), which is involved in metabolism of steroid hormones and polycyclic aromatic hydrocarbons in humans. A genetic polymorphism coding for a valine to isoleucine substitution in exon 7 has been associated with lung cancer risk in Japanese populations. In a previous study, we found no association between CYP1A1 genotype and breast cancer risk. However, we were interested in determining whether genotype would relate to risk when PCB body burden was taken into account. In a subset of a case-control study in western New York, 154 postmenopausal women with incident, primary, histologically confirmed postmenopausal breast cancer and 192 community controls were interviewed and underwent phlebotomy. Serum levels of 56 PCB peaks were determined by high resolution gas chromatography with electron capture. PCR-RFLP analyses of the CYP1A1 polymorphism were performed. Unconditional logistic regression was used to compute adjusted odds ratios and 95% confidence intervals. Among women with serum PCB levels above the median of the distribution in the control group, there was increased risk of breast cancer associated with the presence of at least one valine allele, compared with women who were homozygous for the isoleucine alleles (odds ratio, 2.93; 95% confidence interval, 1.17-7.36). Among women with low PCB body burden, no association between CYP1A1 genotype and breast cancer risk was observed. Adjustment for serum lipids and body mass index did not affect the magnitude of the observed associations. PCB body burden may modify the effect of the polymorphism on postmenopausal breast cancer risk through increased CYP1A1 enzyme induction or by activation by specific PCB congeners. These results should be considered preliminary, pending replication by other studies.

AB - In experimental systems, polychlorinated biphenyls (PCBs) induce cytochrome P4501A1 (CYP1A1), which is involved in metabolism of steroid hormones and polycyclic aromatic hydrocarbons in humans. A genetic polymorphism coding for a valine to isoleucine substitution in exon 7 has been associated with lung cancer risk in Japanese populations. In a previous study, we found no association between CYP1A1 genotype and breast cancer risk. However, we were interested in determining whether genotype would relate to risk when PCB body burden was taken into account. In a subset of a case-control study in western New York, 154 postmenopausal women with incident, primary, histologically confirmed postmenopausal breast cancer and 192 community controls were interviewed and underwent phlebotomy. Serum levels of 56 PCB peaks were determined by high resolution gas chromatography with electron capture. PCR-RFLP analyses of the CYP1A1 polymorphism were performed. Unconditional logistic regression was used to compute adjusted odds ratios and 95% confidence intervals. Among women with serum PCB levels above the median of the distribution in the control group, there was increased risk of breast cancer associated with the presence of at least one valine allele, compared with women who were homozygous for the isoleucine alleles (odds ratio, 2.93; 95% confidence interval, 1.17-7.36). Among women with low PCB body burden, no association between CYP1A1 genotype and breast cancer risk was observed. Adjustment for serum lipids and body mass index did not affect the magnitude of the observed associations. PCB body burden may modify the effect of the polymorphism on postmenopausal breast cancer risk through increased CYP1A1 enzyme induction or by activation by specific PCB congeners. These results should be considered preliminary, pending replication by other studies.

UR - http://www.scopus.com/inward/record.url?scp=0033065636&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033065636&partnerID=8YFLogxK

M3 - Article

C2 - 9950238

AN - SCOPUS:0033065636

VL - 8

SP - 41

EP - 44

JO - Cancer Epidemiology Biomarkers and Prevention

JF - Cancer Epidemiology Biomarkers and Prevention

SN - 1055-9965

IS - 1

ER -